Zevra Therapeutics, Inc. ROE

The ROE as of November 2026 (TTM) for Zevra Therapeutics, Inc. (ZVRA) is 32.77%

According to Zevra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 32.77%. This represents a change of 338.49% compared to the average of 7.47% of the last 4 quarters.

Zevra Therapeutics, Inc. (ZVRA) Historical ROE (quarterly & annually)

How has ZVRA ROE performed in the past?

The mean historical ROE of Zevra Therapeutics, Inc. over the last ten years is -2.82%. The current 32.77% ROE has changed -1260.24% with respect to the historical average. Over the past ten years (40 quarters), ZVRA's ROE was at its highest in in the September 2016 quarter at 136.85%. The ROE was at its lowest in in the December 2024 quarter at -90.10%.

Zevra Therapeutics, Inc. (ZVRA) ROE by Quarter and Year

Discovering the peaks and valleys of Zevra Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zevra Therapeutics, Inc. (ZVRA) Average ROE

How has ZVRA ROE performed in the past?

The current ROE of Zevra Therapeutics, Inc. (ZVRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zevra Therapeutics, Inc. (ZVRA) ROE vs. Peers

How is ZVRA’s ROE compared to its peers?

Zevra Therapeutics, Inc.’s ROE is greater than Supernus Pharmaceuticals, Inc. (-4.14%), less than Neurocrine Biosciences, Inc. (21.13%), less than Alkermes plc (3.72%), greater than Neumora Therapeutics, Inc. Common Stock (-242.28%), greater than MapLight Therapeutics, Inc. (-63.84%), greater than Praxis Precision Medicines, Inc. (-34.15%), less than Jazz Pharmaceuticals plc (21.37%), greater than GH Research PLC (-20.86%), greater than Xenon Pharmaceuticals Inc. (-43.98%), greater than Alto Neuroscience, Inc. (-46.46%),

Build a custom stock screener for Zevra Therapeutics, Inc. (ZVRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zevra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zevra Therapeutics, Inc. (ZVRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zevra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.